Bruker (BRKR) Secures New Orders for High-Performance NMR Instruments Across Top U.S. Research Centers

Core Insights - Bruker Corporation (NASDAQ:BRKR) is recognized as one of the top medical device stocks to invest in, having received new orders for advanced Nuclear Magnetic Resonance (NMR) instruments valued at nearly $10 million from three major US research organizations [1] Group 1: Orders and Clients - The New York Structural Biology Center (NYSBC) has ordered the first Multifield NMR Relaxometry System in North America [2] - The University of Delaware utilized NSF funding to acquire a 600 MHz Dynamic Nuclear Polarization NMR spectrometer for its Department of Chemistry and Biochemistry [2] - Northwestern University has placed an order for an 800 MHz NMR spectrometer, which will support over 15 NIH-funded research groups and the broader Chicago research community [3] Group 2: Company Overview - Bruker Corporation is a leading American manufacturer of high-performance scientific equipment, focusing on tools for molecular and materials research, as well as industrial analysis [3]